Pelthos Therapeutics (PTHS) AGM 2026 summary

Opening remarks and agenda

• The meeting was called to order by the CEO, who outlined the virtual format and rules of conduct for participation and voting.

• Notice of the meeting was confirmed as duly given, and the meeting was officially convened.

Board and executive committee updates

• Eight board nominees, including the CEO, were presented for election to serve until the next annual meeting or until successors are elected.

• No additional nominations were received before the deadline, and nominations were declared closed.

Shareholder proposals

• Three proposals were presented: election of directors, ratification of the independent auditor, and approval of the 2026 equity incentive plan.

• The board recommended a vote in favor of all three proposals.